Baker Brothers Advisors - MARKER THERAPEUTICS INC ownership

MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 72 filers reported holding MARKER THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of MARKER THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$498,000
-82.2%
240,505
-83.6%
0.00%
-88.2%
Q1 2020$2,793,000
-35.3%
1,470,198
-2.0%
0.02%
-26.1%
Q4 2019$4,320,000
-43.6%
1,500,0000.0%0.02%
-55.8%
Q3 2019$7,665,000
-35.5%
1,500,0000.0%0.05%
-35.8%
Q2 2019$11,880,000
+20.0%
1,500,0000.0%0.08%
+28.6%
Q1 2019$9,900,000
+18.9%
1,500,0000.0%0.06%
-7.4%
Q4 2018$8,325,0001,500,0000.07%
Other shareholders
MARKER THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Aisling Capital Management LP 3,142,857$2,986,0001.05%
ACT CAPITAL MANAGEMENT, LLC 354,400$337,0000.24%
NEA Management Company, LLC 10,714,285$10,179,0000.21%
Long Focus Capital Management, LLC 1,233,257$1,172,0000.16%
Mandatum Life Insurance Co Ltd 99,000$94,0000.02%
MATRIX ASSET ADVISORS INC/NY 150,000$143,0000.02%
AR ASSET MANAGEMENT INC 71,500$68,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 590,118$561,0000.01%
WealthTrust Axiom LLC 22,700$21,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 324,216$308,0000.01%
View complete list of MARKER THERAPEUTICS INC shareholders